Literature DB >> 16676364

The North Carolina-Louisiana Prostate Cancer Project (PCaP): methods and design of a multidisciplinary population-based cohort study of racial differences in prostate cancer outcomes.

Jane C Schroeder1, Jeannette T Bensen, L Joseph Su, Merle Mishel, Anastasia Ivanova, Gary J Smith, Paul A Godley, Elizabeth T H Fontham, James L Mohler.   

Abstract

BACKGROUND: The North Carolina-Louisiana Prostate Cancer Project (PCaP) is a multidisciplinary study of social, individual, and tumor-level causes of racial differences in prostate cancer aggressiveness.
METHODS: A population-based sample of incident prostate cancer cases from North Carolina and Louisiana will include 1,000 African Americans and 1,000 Caucasian Americans. Study nurses administer structured questionnaires and collect blood, adipose tissue, urine, and toenail samples during an in-home visit. Clinical data are abstracted from medical records, diagnostic biopsies are reviewed and assayed, and tissue microarrays are constructed from prostatectomy samples. Prostate cancer aggressiveness is classified based on PSA, clinical stage, and Gleason grade.
RESULTS: Preliminary data demonstrate between- and within-group differences in patient characteristics, screening, and treatment by race and state. Participation exceeds 70% in all groups.
CONCLUSIONS: Preliminary data support the feasibility of this comprehensive study to help determine the focus of public health efforts to reduce racial disparities in prostate cancer mortality. (c) 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16676364     DOI: 10.1002/pros.20449

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  36 in total

1.  The Association of Diabetes and Obesity With Prostate Cancer Progression: HCaP-NC.

Authors:  Saira Khan; Jianwen Cai; Matthew E Nielsen; Melissa A Troester; James L Mohler; Elizabeth T H Fontham; Laura H Hendrix; Laura Farnan; Andrew F Olshan; Jeannette T Bensen
Journal:  Prostate       Date:  2017-03-06       Impact factor: 4.104

2.  Carotenoid intake and adipose tissue carotenoid levels in relation to prostate cancer aggressiveness among African-American and European-American men in the North Carolina-Louisiana prostate cancer project (PCaP).

Authors:  Samuel O Antwi; Susan E Steck; L Joseph Su; James R Hebert; Hongmei Zhang; Neal E Craft; Elizabeth T H Fontham; Gary J Smith; Jeannette T Bensen; James L Mohler; Lenore Arab
Journal:  Prostate       Date:  2016-06-08       Impact factor: 4.104

3.  Disparities in castration-resistant prostate cancer trials.

Authors:  Daniel E Spratt; Joseph R Osborne
Journal:  J Clin Oncol       Date:  2015-02-17       Impact factor: 44.544

4.  The association of metformin use with prostate cancer aggressiveness among Black Americans and White Americans in a population-based study.

Authors:  Saira Khan; Jianwen Cai; Matthew E Nielsen; Melissa A Troester; James L Mohler; Elizabeth T H Fontham; Laura Farnan; Bettina F Drake; Andrew F Olshan; Jeannette T Bensen
Journal:  Cancer Causes Control       Date:  2018-09-28       Impact factor: 2.506

5.  Frailty and Comorbidities Among Survivors of Adolescent and Young Adult Cancer: A Cross-Sectional Examination of a Hospital-Based Survivorship Cohort.

Authors:  Andrew B Smitherman; Chelsea Anderson; Jennifer L Lund; Jeannette T Bensen; Donald L Rosenstein; Hazel B Nichols
Journal:  J Adolesc Young Adult Oncol       Date:  2018-03-23       Impact factor: 2.223

6.  Serum glutamate levels correlate with Gleason score and glutamate blockade decreases proliferation, migration, and invasion and induces apoptosis in prostate cancer cells.

Authors:  Shahriar Koochekpour; Sunipa Majumdar; Gissou Azabdaftari; Kristopher Attwood; Ray Scioneaux; Dhatchayini Subramani; Charles Manhardt; Giovanni D Lorusso; Stacey S Willard; Hillary Thompson; Mojgan Shourideh; Katayoon Rezaei; Oliver Sartor; James L Mohler; Robert L Vessella
Journal:  Clin Cancer Res       Date:  2012-10-16       Impact factor: 12.531

7.  Patient-health care provider communication among patients with newly diagnosed prostate cancer: findings from a population-based survey.

Authors:  Lixin Song; Jeannette T Bensen; Catherine Zimmer; Betsy Sleath; Bonny Blackard; Elizabeth Fontham; L Joseph Su; Christine S Brennan; James L Mohler; Merle Mishel
Journal:  Patient Educ Couns       Date:  2013-01-15

8.  The association between calcium channel blocker use and prostate cancer outcome.

Authors:  Michael A Poch; Diana Mehedint; Dawn J Green; Rochelle Payne-Ondracek; Elizabeth T H Fontham; Jeannette T Bensen; Kristopher Attwood; Gregory E Wilding; Khurshid A Guru; Willie Underwood; James L Mohler; Hannelore V Heemers
Journal:  Prostate       Date:  2012-12-31       Impact factor: 4.104

9.  Racial differences in trust and regular source of patient care and the implications for prostate cancer screening use.

Authors:  William R Carpenter; Paul A Godley; Jack A Clark; James A Talcott; Timothy Finnegan; Merle Mishel; Jeannette Bensen; Walter Rayford; L Joseph Su; Elizabeth T H Fontham; James L Mohler
Journal:  Cancer       Date:  2009-11-01       Impact factor: 6.860

10.  Comparison of ACINUS, caspase-3, and TUNEL as apoptotic markers in determination of tumor growth rates of clinically localized prostate cancer using image analysis.

Authors:  Swaroop S Singh; Diana C Mehedint; O Harris Ford; D Antony Jeyaraj; Elena A Pop; Susan J Maygarden; Anastasia Ivanova; Rameela Chandrasekhar; Gregory E Wilding; James L Mohler
Journal:  Prostate       Date:  2009-11-01       Impact factor: 4.104

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.